glp 1 weight loss medications The New Management Meds A Guide to Weight-Loss Medications:

As more people take the drug, the number of people experiencing severe side effects will also increase

Since gastric distension (both of the proximal and distal stomach) can lead to reduced food/energy intake (64, 65), the question arises as to whether the slowing of gastric emptying, via increased gastric distension, contributes to the regulation of appetite and energy intake

Moreover, because adverse effects are more prevalent at higher GLP-1 RA doses, discontinuation of these medications might lead to a high likelihood of side-effects upon medication reinitiation or require reinitiation of therapy at lower doses followed by dose reescalation

FEEL THE DIFFERENCE IN DAYS, NOT WEEKS Day 13: Magnesium begins softening stool and improving motility

doi:10.3945/ajcn.2009.28449C 10

Cardiovascular protection Randomised controlled cardiovascular outcome trials (CVOTs) have shown that liraglutide, dulaglutide and semaglutide reduce major adverse cardiovascular events (MACE